# Thalidomide in Treating Patients With Gynecologic Sarcomas

> **NCT00006005** · PHASE2 · COMPLETED · sponsor: **New York University Cancer Institute**

## Conditions studied

- Endometrial Cancer
- Sarcoma

## Interventions

- **DRUG:** thalidomide

## Key facts

- **NCT ID:** NCT00006005
- **Lead sponsor:** New York University Cancer Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2000-09
- **Primary completion:** —
- **Final completion:** 2006-08
- **Target enrollment:** — (—)
- **Last updated:** 2013-06-21

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00006005

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00006005, "Thalidomide in Treating Patients With Gynecologic Sarcomas". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00006005. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*